MAP
NAMS icon

Moody Aldrich Partners’s NewAmsterdam Pharma NAMS Stock Holding History

Moody Aldrich Partners’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07M Sell
90,617
-24,358
-21% -$803K 0.55% 88
2026
Q1 		$3.68M Sell
114,975
-28,574
-20% -$931K 0.66% 72
2025
Q4 		$5.04M Buy
+143,549
New +$5.22M 0.94% 34
2025
Q1 		– Sell
-79,145
Closed -$2.03M – 203
2024
Q4 		$2.03M Sell
79,145
-137,348
-63% -$2.92M 0.38% 93
2024
Q3 		$3.59M Sell
216,493
-4,174
-2% -$72.2K 0.65% 70
2024
Q2 		$4.24M Buy
220,667
+109,400
+98% +$2.19M 0.83% 57
2024
Q1 		$2.63M Buy
+111,267
New +$2.26M 0.45% 83

Other funds holding NAMS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
TSMHT
Thurston Springer Miller Herd & Titak Indianapolis, Indiana $275M AUM 30.64% 1-Year Est. Return
RF
Roxbury Financial Mount Arlington, New Jersey $126M AUM 23.88% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return